Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lawrence Scherr is active.

Publication


Featured researches published by Lawrence Scherr.


The New England Journal of Medicine | 1983

Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion.

Lawrence Ong; Peter Reiser; James Coromilas; Lawrence Scherr; John J. Morrison

Intracoronary thrombolysis during acute myocardial infarction in human beings is associated with rapid release of creatine kinase and improvement of the cardiac ejection fraction. To examine the phenomenon of spontaneous coronary-artery recanalization, we studied the release of creatine kinase MB and sequential radionuclide ventriculograms in 52 patients with transmural myocardial infarction. Patients were divided into two groups according to whether the release of creatine kinase MB (time from base-line to peak serum level) was rapid (n = 24) or slow (n = 28). Patients with slow release had no significant change in global or regional ejection fraction from the time of admission to discharge. However, global ejection fraction in patients with rapid release improved from 0.38 +/- 0.09 (mean +/- S.D.) to 0.48 +/- 0.08 (P less than 0.001). The regional ejection fraction of Q-wave regions also improved, from 0.33 +/- 0.11 to 0.43 +/- 0.13 (P less than 0.001). A negative correlation (r = -0.52, P less than 0.001) existed between time to peak enzyme level and degree of improvement in ejection fraction. With increasing left ventricular damage, patients with rapid release had greater increments in creatine kinase MB than comparable patients with slow release (P = 0.03), suggesting enzyme washout. These data are consistent with the idea that spontaneous reperfusion, leading to altered enzyme release and improvement in ventricular function, is not uncommon after acute myocardial infarction.


American Heart Journal | 1961

The management of resistant fluid-retention states with intravenous L-arginine monohydrochloride in combination with mercurial diuretics

David A. Ogden; Lawrence Scherr; Norton Spritz; Albert L. Rubin; E.Hugh Luckey

Abstract The daily intravenous administration of a large dose of l -arginine monohydrochloride is a safe and effective method of producing hyperchloremic acidosis and restoring responsiveness to mercurial diuretics in patients with refractory retention of fluid due to hepatic cirrhosis or congestive heart failure. Results obtained with 5 patients thus treated, and the advantages of this agent in certain clinical situations, are discussed.


Annals of Internal Medicine | 1987

Graduate Medical Education: A Vital Renewal for Internal Medicine

Lawrence Scherr

Excerpt In this issue, the Federated Council for Internal Medicine (FCIM) states its position on methods to enhance excellence in internal medicine through graduate training programs and the method...


Annals of Internal Medicine | 1962

An Unusual Clinical SignMydriasis Associated with Hyperkalemia and Metabolic Acidosis

Lawrence Scherr; Glenn D. Lubash; Albert L. Rubin; E. Hugh Luckey

Excerpt Muscle paresis or paralysis is infrequently associated with hyperkalemia (1-3). This relationship was noted in the case presented here and was particularly interesting because of associated...


The New England Journal of Medicine | 1961

Management of Hyperkalemia with a Cation-Exchange Resin

Lawrence Scherr; David A. Ogden; Allen W. Mead; Norton Spritz; Albert L. Rubin


JAMA | 1962

Acute Renal Failure Associated with Carbon Tetrachloride Intoxication

Peter S. New; Glenn D. Lubash; Lawrence Scherr; Albert L. Rubin


The New England Journal of Medicine | 1961

A comparison of the properties of chlorothiazide, spironolactone and a combination of both as diuretic agents.

David A. Ogden; Lawrence Scherr; Norton Spritz; Albert L. Rubin


American Heart Journal | 1958

The spatial vectorcardiogram in complete left bundle branch block with special reference to the initial component.

George W. Frimpter; Lawrence Scherr; David A. Ogden


JAMA Internal Medicine | 1962

Sedative Overdosage and the Role of Hemodialysis

Glenn D. Lubash; M. Jeanne Ferrari; Lawrence Scherr; Albert L. Rubin


JAMA | 1964

Diabetic Keto Acidosis: Dissociation of Plasma Potassium Levels and Electrocardiographic Abnormalities

Kurt H. Stenzel; Joseph C. Dougherty; Lawrence Scherr; Glenn D. Lubash

Collaboration


Dive into the Lawrence Scherr's collaboration.

Top Co-Authors

Avatar

Albert L. Rubin

American Heart Association

View shared research outputs
Top Co-Authors

Avatar

David A. Ogden

American College of Physicians

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Norton Spritz

American Heart Association

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lawrence Ong

North Shore University Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge